Search Results - "Schnitzler, M.A."

Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys by Medina Pestana, J. O., Grinyo, J. M., Vanrenterghem, Y., Becker, T., Campistol, J. M., Florman, S., Garcia, V. D., Kamar, N., Lang, P., Manfro, R. C., Massari, P., Rial, M. D. C., Schnitzler, M. A., Vitko, S., Duan, T., Block, A., Harler, M. B., Durrbach, A.

“…Recipients of extended‐criteria donor (ECD) kidneys have poorer long‐term outcomes compared to standard‐criteria donor kidney recipients. We report 3‐year…”
Get full text

The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis by Axelrod, D. A., Schnitzler, M. A., Xiao, H., Naik, A. S., Segev, D. L., Dharnidharka, V. R., Brennan, D. C., Lentine, K. L.

“…Kidney transplantation has become more resource intensive as recipient complexity has increased and average donor quality has diminished over time. A national…”
Get full text

Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients by Khoury, J. A., Storch, G. A., Bohl, D. L., Schuessler, R. M., Torrence, S. M., Lockwood, M., Gaudreault‐Keener, M., Koch, M. J., Miller, B. W., Hardinger, K. L., Schnitzler, M. A., Brennan, D. C.

“…Prophylaxis reduces cytomegalovirus (CMV) disease, but is associated with increased costs and risks for side effects, viral resistance and late onset CMV…”
Get full text

A Retrospective Analysis of Immunosuppression Compliance, Dose Reduction and Discontinuation in Kidney Transplant Recipients by Takemoto, S. K., Pinsky, B. W., Schnitzler, M. A., Lentine, K. L., Willoughby, L. M., Burroughs, T. E., Bunnapradist, S.

“…We describe factors associated with poor compliance and dose reductions and examine the relative impact of compliance, dose reduction and discontinuation on…”
Get full text

The Clinical Importance of Flow Cytometry Crossmatch in the Context of CDC Crossmatch Results by Graff, R.J, Buchanan, P.M, Dzebisashvili, N, Schnitzler, M.A, Tuttle-Newhall, J, Xiao, H, Schadde, E, Gheorghian, A, Lentine, K.L

“…Abstract Background The complement-dependent microcytotoxicity crossmatch (CDCXM) is a standard method for evaluating the presence of preformed antibodies…”
Get full text

Patient and Graft Survival Implications of Simultaneous Pancreas Kidney Transplantation From Old Donors by Salvalaggio, P. R., Schnitzler, M. A., Abbott, K. C., Brennan, D. C., Irish, W., Takemoto, S. K., Axelrod, D., Santos, L. S., Kocak, B., Willoughby, L., Lentine, K. L.

“…We investigated graft and patient survival implications of simultaneous pancreas kidney (SPK) transplant from old donors. Data describing patients with type 1…”
Get full text

9: Impact of ischemia time on the outcomes of heart transplant by Schnitzler, M.A, Buchanan, P.M, Burroughs, T.E, Lee, R, Hauptman, P.J

Get full text

7: The cost-effectiveness of increasing the supply of hearts for transplant by Schnitzler, M.A, Buchanan, P.M, Swindle, J, Lee, R, Hauptman, P.J

Get full text

OPTN/SRTR 2012 Annual Data Report: Kidney by Matas, A. J., Smith, J. M., Skeans, M. A., Thompson, B., Gustafson, S. K., Schnitzler, M. A., Stewart, D. E., Cherikh, W. S., Wainright, J. L., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT For most end‐stage renal disease patients, successful kidney transplant provides substantially longer survival and better quality of life than…”
Get full text

A Risk Prediction Model for Delayed Graft Function in the Current Era of Deceased Donor Renal Transplantation by Irish, W. D., Ilsley, J. N., Schnitzler, M. A., Feng, S., Brennan, D. C.

“…Delayed graft function (DGF) impacts short‐ and long‐term outcomes. We present a model for predicting DGF after renal transplantation. A multivariable logistic…”
Get full text

OPTN/SRTR 2012 Annual Data Report: Liver by Kim, W. R., Smith, J. M., Skeans, M. A., Schladt, D. P., Schnitzler, M. A., Edwards, E. B., Harper, A. M., Wainright, J. L., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT Liver transplant in the us remains a successful life‐saving procedure for patients with irreversible liver disease. In 2012, 6256 adult liver…”
Get full text

Perioperative Complications After Living Kidney Donation: A National Study by Lentine, K. L., Lam, N. N., Axelrod, D., Schnitzler, M. A., Garg, A. X., Xiao, H., Dzebisashvili, N., Schold, J. D., Brennan, D. C., Randall, H., King, E. A., Segev, D. L.

“…We integrated the US transplant registry with administrative records from an academic hospital consortium (97 centers, 2008–2012) to identify predonation…”
Get full text

Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression by Pinsky, B. W., Takemoto, S. K., Lentine, K. L., Burroughs, T. E., Schnitzler, M. A., Salvalaggio, P. R.

“…We describe factors associated with immunosuppression compliance after kidney transplantation and examine relationships between compliance with allograft…”
Get full text

The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes by Axelrod, D. A., Schnitzler, M. A., Alhamad, T., Gordon, F., Bloom, R. D., Hess, G. P., Xiao, H., Nazzal, M., Segev, D. L., Dharnidharka, V. R., Naik, A. S., Lam, N. N., Ouseph, R., Kasiske, B. L., Durand, C. M., Lentine, K. L.

“…Direct‐acting antiviral medications (DAAs) have revolutionized care for hepatitis C positive (HCV+) liver (LT) and kidney (KT) transplant recipients…”
Get full text

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes by Lentine, K. L., Lam, N. N., Naik, A. S., Axelrod, D. A., Zhang, Z., Dharnidharka, V. R., Hess, G. P., Segev, D. L., Ouseph, R., Randall, H., Alhamad, T., Devraj, R., Gadi, R., Kasiske, B. L., Brennan, D. C., Schnitzler, M. A.

“…Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S…”
Get full text

OPTN/SRTR 2016 Annual Data Report: Economics by Schnitzler, M. A., Skeans, M. A., Axelrod, D. A., Lentine, K. L., Randall, H. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per‐person…”
Get full text

MELD Exceptions and Rates of Waiting List Outcomes by Massie, A. B., Caffo, B., Gentry, S. E., Hall, E. C., Axelrod, D. A., Lentine, K. L., Schnitzler, M. A., Gheorghian, A., Salvalaggio, P. R., Segev, D. L.

“…Model for End‐stage Liver Disease (MELD)‐based allocation of deceased donor livers allows exceptions for patients whose score may not reflect their true…”
Get full text

Addressing Geographic Disparities in Liver Transplantation Through Redistricting by Gentry, S. E., Massie, A. B., Cheek, S. W., Lentine, K. L., Chow, E. H., Wickliffe, C. E., Dzebashvili, N., Salvalaggio, P. R., Schnitzler, M. A., Axelrod, D. A., Segev, D. L.

“…Severe geographic disparities exist in liver transplantation; for patients with comparable disease severity, 90‐day transplant rates range from 18% to 86% and…”
Get full text

OPTN/SRTR 2012 Annual Data Report: Lung by Valapour, M., Skeans, M. A., Heubner, B. M., Smith, J. M., Schnitzler, M. A., Hertz, M. I., Edwards, L. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT Lung transplants are increasingly used as treatment for end‐stage lung diseases not amenable to other medical and surgical therapies. Lungs are…”
Get full text

Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice by Dharnidharka, Vikas R, Naik, Abhijit S, Axelrod, David A, Schnitzler, Mark A, Zhang, Zidong, Bae, Sunjae, Segev, Dorry L, Brennan, Daniel C, Alhamad, Tarek, Ouseph, Rosemary, Lam, Ngan N, Nazzal, Mustafa, Randall, Henry, Kasiske, Bertram L, McAdams-Demarco, Mara, Lentine, Krista L

“…To assess factors that influence the choice of induction regimen in contemporary kidney transplantation, we examined center-identified, national transplant…”
Get more information